The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 ...

A judge intends to rule this week on a plan for local governments and individual victims to vote on OxyContin maker Purdue ...

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of ...

The long-running Purdue Pharma case may finally be over. All attorneys general from U.S. states, territories, districts and ...

Nebraska could see as much as $19.7 million from the settlement if it moves forward, according to Attorney General Mike ...

The $7.4 billion nationwide settlement with provide state and local governments with funds for opioid treatment efforts, said ...

A $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family, was agreed to be signed by 55 attorneys ...

A $7.4 billion settlement agreement with the founders of Purdue Pharma is almost sealed in ink — and Utah will get $57 ...

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and ...

T he $7.4 billion settlement involves Purdue Pharma, the maker of OxyContin, and the Sackler family, who own the company.

The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement with 55 U.S. attorneys general to address the ...

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.